WILMINGTON, DE — Incyte (Nasdaq: INCY) is scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, providing investors with an opportunity to hear updates from the biotechnology company as it advances its portfolio across oncology, hematology, and immunology markets.
The presentation is set for 8:40 a.m. EDT and will be available through a live webcast, the company said.
Investor conference appearances are closely watched by analysts and shareholders for insights into commercial performance, clinical development programs, regulatory milestones, and capital allocation priorities.
Incyte said a live webcast and replay of the presentation will be available through the investor relations section of its website.
The webcast can be accessed at:
https://Investor.Incyte.com
A replay will remain available for 30 days following the presentation.
Incyte develops and markets therapies focused on hematology, oncology, inflammation, and autoimmune diseases. The company maintains a portfolio of approved medicines and investigational treatments across multiple therapeutic areas.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.